Clinical Trial Update: Cannabidiol in Sickle Cell Disease [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating cannabidiol for sickle cell disease is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Drugs mentioned

• EPIDIOLEX (Cannabidiol)

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Sickle Cell Disease | Phase 1, Phase 2 | Status: RECRUITING